171 related articles for article (PubMed ID: 11325076)
1. Effects of AT1 receptor antagonist on proteoglycan gene expression in hypertensive rats.
Sasamura H; Shimizu-Hirota R; Nakaya H; Saruta T
Hypertens Res; 2001 Mar; 24(2):165-72. PubMed ID: 11325076
[TBL] [Abstract][Full Text] [Related]
2. Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.
Kim S; Iwao H
J Hypertens Suppl; 1997 Dec; 15(6):S3-7. PubMed ID: 9493120
[TBL] [Abstract][Full Text] [Related]
3. Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats.
Obata J; Nakamura T; Takano H; Naito A; Kimura H; Yoshida Y; Shimizu F; Guo DF; Inagami T
J Hypertens; 2000 Sep; 18(9):1247-55. PubMed ID: 10994756
[TBL] [Abstract][Full Text] [Related]
4. Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
Kidney Int; 1994 Nov; 46(5):1346-58. PubMed ID: 7853793
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Ishimura Y; Chatani F; Iwao H
J Pharmacol Exp Ther; 1995 Apr; 273(1):509-15. PubMed ID: 7714806
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats.
Kim S; Zhan Y; Izumi Y; Iwao H
Hypertension; 2000 Mar; 35(3):769-74. PubMed ID: 10720593
[TBL] [Abstract][Full Text] [Related]
7. Effects of AT1 receptor antagonist and spironolactone on cardiac expression of ET-1 mRNA in SHR-SP/Izm.
Naruse M; Tanabe A; Hara Y; Takagi S; Imaki T; Takano K
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S1-3. PubMed ID: 15838251
[TBL] [Abstract][Full Text] [Related]
8. Renal protective effect of TCV-116 in stroke-prone spontaneously hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
Blood Press Suppl; 1994; 5():54-6. PubMed ID: 7889201
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin AT1 receptor antagonism and protection against cardiovascular end-organ damage.
Nishikawa K
J Hum Hypertens; 1998 May; 12(5):301-9. PubMed ID: 9655651
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the antihypertensive effects of the new angiotensin II (AT1) receptor antagonist candesartan cilexetil (TCV-116) and the angiotensin converting enzyme inhibitor enalapril in rats.
Wada T; Inada Y; Ojima M; Sanada T; Shibouta Y; Nishikawa K
Hypertens Res; 1996 Jun; 19(2):75-81. PubMed ID: 10968199
[TBL] [Abstract][Full Text] [Related]
11. Distinct rat aortic smooth muscle cells differ in versican/PG-M expression.
Lemire JM; Potter-Perigo S; Hall KL; Wight TN; Schwartz SM
Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):821-9. PubMed ID: 8640411
[TBL] [Abstract][Full Text] [Related]
12. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
Paull JR; Widdop RE
J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
[TBL] [Abstract][Full Text] [Related]
13. KRH-594, a new angiotensin AT1 receptor antagonist, prevents end-organ damage in stroke-prone spontaneously hypertensive/Izm rats.
Inada Y; Tazawa S; Murakami M; Akahane M
Clin Exp Pharmacol Physiol; 2001 Mar; 28(3):206-11. PubMed ID: 11207677
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats.
Inada Y; Wada T; Ojima M; Sanada T; Shibouta Y; Kanagawa R; Ishimura Y; Fujisawa Y; Nishikawa K
Clin Exp Hypertens; 1997 Oct; 19(7):1079-99. PubMed ID: 9310205
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of extracellular matrix proteoglycan (PG) gene expression. Transforming growth factor-beta 1 up-regulates biglycan (PGI), and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA levels in human fibroblasts in culture.
Kähäri VM; Larjava H; Uitto J
J Biol Chem; 1991 Jun; 266(16):10608-15. PubMed ID: 2037600
[TBL] [Abstract][Full Text] [Related]
16. Effects of angiotensin inhibitors on renal injury and angiotensin receptor expression in early hypertensive nephrosclerosis.
Nakaya H; Sasamura H; Kitamura Y; Amemiya T; Konishi K; Hayashi M; Saruta T
Hypertens Res; 1999 Nov; 22(4):303-12. PubMed ID: 10580398
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II-dependent down-regulation of vascular natriuretic peptide type C receptor gene expression in hypertensive rats.
Yoshimoto T; Naruse M; Naruse K; Shionoya K; Tanaka M; Tanabe A; Hagiwara H; Hirose S; Muraki T; Demura H
Endocrinology; 1996 Mar; 137(3):1102-7. PubMed ID: 8603580
[TBL] [Abstract][Full Text] [Related]
18. Candesartan cilexetil reduces chronic renal allograft injury in Fisher-->Lewis rats.
Mackenzie HS; Ziai F; Nagano H; Azuma H; Troy JL; Rennke HG; Tilney NL; Brenner BM
J Hypertens Suppl; 1997 Dec; 15(6):S21-5. PubMed ID: 9493123
[TBL] [Abstract][Full Text] [Related]
19. Combined blockade of AT1-receptors and ACE synergistically potentiates antihypertensive effects in SHR.
Raasch W; Jöhren O; Schwartz S; Gieselberg A; Dominiak P
J Hypertens; 2004 Mar; 22(3):611-8. PubMed ID: 15076168
[TBL] [Abstract][Full Text] [Related]
20. Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Yukimura T; Miura K; Iwao H
Br J Pharmacol; 1996 Jun; 118(3):549-56. PubMed ID: 8762077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
